We are live on ! Find out more
JPMIA

J.P. Marvel Investment Advisors Portfolio holdings

AUM $705M
1-Year Est. Return 43.01%
This Fund
S&P 500
This Quarter Est. Return
+5.51%
1 Year Est. Return
+43.01%
3 Year Est. Return
+140.86%
5 Year Est. Return
+213.54%
10 Year Est. Return
AUM
$285M
AUM Growth
+$7.78M
Cap. Flow
-$4.74M
Cap. Flow %
-1.66%
Top 10 Hldgs %
36.27%
Holding
89
New
3
Increased
5
Reduced
51
Closed
9

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$4.99M
2
GT icon
Goodyear
GT
+$2.13M
3
STR
QUESTAR CORP
STR
+$856K
4
ALKS icon
Alkermes
ALKS
+$617K
5
ADP icon
Automatic Data Processing
ADP
+$580K

Sector Composition

Rank Sector Weight
1 Healthcare 31.28%
2 Communication Services 10.08%
3 Financials 9.92%
4 Industrials 9.54%
5 Technology 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$127B
$14.6M 5.1%
198,062
-3,842
-2% -$271K
TMO icon
2
Thermo Fisher Scientific
TMO
$211B
$12.5M 4.36%
84,320
-1,159
-1% -$171K
SBUX icon
3
Starbucks
SBUX
$118B
$12.3M 4.32%
215,936
-4,895
-2% -$278K
JNJ icon
4
Johnson & Johnson
JNJ
$635B
$9.97M 3.49%
82,174
-1,760
-2% -$200K
JPM icon
5
JPMorgan Chase
JPM
$939B
$9.85M 3.45%
158,514
-3,369
-2% -$210K
PFE icon
6
Pfizer
PFE
$140B
$9.62M 3.37%
287,925
-4,451
-2% -$142K
LEA icon
7
Lear
LEA
$7.19B
$9.26M 3.24%
91,016
-1,945
-2% -$219K
MON
8
DELISTED
Monsanto Co
MON
$9.02M 3.16%
87,174
-1,648
-2% -$163K
GE icon
9
GE Aerospace
GE
$367B
$8.98M 3.15%
59,519
-1,883
-3% -$275K
EOG icon
10
EOG Resources
EOG
$78B
$7.49M 2.62%
89,796
-2,444
-3% -$196K
NVS icon
11
Novartis
NVS
$295B
$7.11M 2.49%
96,214
-1,149
-1% -$79.4K
SLB icon
12
SLB Ltd
SLB
$77.8B
$7.03M 2.46%
88,912
-594
-0.7% -$45.5K
GOOGL icon
13
Alphabet (Google) Class A
GOOGL
$3.91T
$6.72M 2.36%
191,160
-6,240
-3% -$229K
STI
14
DELISTED
SunTrust Banks, Inc.
STI
$6.57M 2.3%
160,009
-2,882
-2% -$118K
CSCO icon
15
Cisco
CSCO
$450B
$6.56M 2.3%
228,666
-5,876
-3% -$165K
BECN
16
DELISTED
Beacon Roofing Supply, Inc.
BECN
$6.37M 2.23%
+140,150
New +$6.03M
CELG
17
DELISTED
Celgene Corp
CELG
$5.94M 2.08%
60,202
-1,348
-2% -$139K
MDT icon
18
Medtronic
MDT
$107B
$5.82M 2.04%
67,081
-282
-0.4% -$22.8K
DIS icon
19
Walt Disney
DIS
$165B
$5.65M 1.98%
57,738
-869
-1% -$86.9K
T icon
20
AT&T
T
$165B
$5.41M 1.89%
165,613
-5,196
-3% -$155K
GLW icon
21
Corning
GLW
$126B
$5.36M 1.88%
261,505
-6,635
-2% -$133K
MS icon
22
Morgan Stanley
MS
$337B
$5.32M 1.86%
204,857
-5,504
-3% -$144K
ABBV icon
23
AbbVie
ABBV
$458B
$5.11M 1.79%
82,508
-1,231
-1% -$75K
AAPL icon
24
Apple
AAPL
$4.89T
$4.92M 1.72%
205,788
-15,488
-7% -$385K
KO icon
25
Coca-Cola
KO
$354B
$4.71M 1.65%
103,962
-2,460
-2% -$111K

Similar funds

J.P. Marvel Investment Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, J.P. Marvel Investment Advisors held 89 positions worth $285M, up 2.8% from $278M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

J.P. Marvel Investment Advisors's Q2 2016 filing shows 3 new, 5 increased, 51 reduced and 9 closed positions. Its largest new stake was Beacon Roofing Supply, Inc.: 140,150 shares worth $6.37M. The largest sale was CVS Health, an estimated $4.99M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Communication Services and Financials.

  • J.P. Marvel Investment Advisors's largest Q2 2016 buy was Beacon Roofing Supply, Inc.: 140,150 shares worth $6.37M.
  • J.P. Marvel Investment Advisors added most to Pioneer Natural Resource Co. in Q2 2016, an estimated $2.26M increase.
  • J.P. Marvel Investment Advisors's biggest Q2 2016 reduction was Alkermes, cutting an estimated $617K.
  • J.P. Marvel Investment Advisors fully exited CVS Health in Q2 2016, selling an estimated $4.99M.
  • J.P. Marvel Investment Advisors's ten largest holdings make up 36% of its $285M portfolio in Q2 2016.
  • J.P. Marvel Investment Advisors opened 3 new positions and closed 9 in Q2 2016.
  • J.P. Marvel Investment Advisors's portfolio value rose 2.8% quarter-over-quarter to $285M.

Based on J.P. Marvel Investment Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.